Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending August 2009. The report discloses a notification received from Legal & General Group plc regarding a change in their major shareholding interest in the registrant, filed in accordance with Disclosure and Transparency Rules (DTR 5.8.12).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory notification of shareholding changes and does not contain financial performance data.
Material Changes
The material change disclosed is a reduction in the voting rights held by Legal & General Group plc and its subsidiaries. Following a transaction on August 19, 2009, the group's total voting rights fell below the 5% threshold. Specifically:
- Legal & General Group Plc (Group): Total voting rights are now below 5%.
- Legal & General Investment Management Limited (LGIM): Total voting rights are now below 5%.
- Legal & General Assurance (Pensions Management) Limited (PMC): Holds 195,647,164 shares representing 3.77% of voting rights.
- Legal & General Group Plc (Direct): Holds 234,245,526 shares representing 4.51% of voting rights.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for management guidance, future outlook, specific risks, contingencies, or unusual items. The document is strictly a notification of a change in beneficial ownership.
Investor Verification Checklist
- Verify the total number of outstanding shares (cited as 5,188,446,713) to confirm the percentage calculations.
- Confirm the specific transaction date of August 19, 2009, that triggered the drop below the 5% threshold.
- Review the breakdown of direct versus indirect holdings within the Legal & General Group structure.
- Check subsequent filings to determine if Legal & General Group has crossed any other reporting thresholds.